Device Trial Radar · NCT00565747
Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF
Last checked: Nov 19, 2026Latest source record: May 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,332
Actual
Start
Nov 2007
Primary completion
Nov 2010
Study completion Sep 2011
Sponsor
- Lead sponsor
- Origio A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 30, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 25 years, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to assess whether addition of 2 ng/ml GM-CSF into a specific culture medium will increase the chance of a pregnancy after in vitro fertilisation.
Conditions
- Infertility
Interventions
Test cultureDevice
A standard culture medium with added GM-CSF (ready-to-use)
Control cultureDevice
The same standard culture medium, but without any additions (ready-to-use)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ongoing Implantation Rate Week 7Time frame: Approximately 5 weeks from oocyte pick-up (corresponding to 7 weeks from ovulation)
Locations
14 sites in 2 countries. Site status is shown where the registry gives one.
Maigaard Fertilitetsklinik
Aarhus, Denmark
Ciconia Aarhus Privathospital, Fertilitetsklinikken
Aarhus, Denmark
Brædstrup Sygehus; IVF-Klinikken
Brædstrup, Denmark
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.